Cancer Gene Therapy - Table of Contents alert Volume 22 Issue 2

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 22, Issue 2 (March 2015) In this issue Editorial Reviews Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature Reviews Clinical Oncology  FREE POSTER: BREAST CANCER INTRINSIC SUBTYPES This special Poster highlights recent achievements and development of our genetic understanding of the intrinsic subtypes of molecular breast cancer subtypes. Produced with support from:  NanoString® Technologies, Inc   Editorial Top Genetically engineered lymphocytes and adoptive cell therapy: cancer immunotherapy’s smart bombs S K Libutti Cancer Gene Ther 2015 22: 63; 10.1038/cgt.2015.1 Full Text Reviews Top Moving from tinkering in the garage to assembly line production: the manufacture of genetically modified T cells expressing chimeric antigen receptors (CARs) comes on line L J N Cooper Cancer Gene Ther 2015 22: 64-66; advance online publication, February 13, 2015; 10.1038/cgt.2014.70 Full Text Manufacturing genetically modified T cells for clinical trials A P Gee Cancer Gene Ther 2015 22: 67-71; advance online publication, January 30, 2015; 10.1038/cgt.2014.71 Abstract | Full Text Towards a commercial process for the manufacture of genetically modified T cells for therapy OPEN A D Kaiser, M Assenmacher, B Schröder, M Meyer, R Orentas, U Bethke and B Dropulic Cancer Gene Ther 2015 22: 72-78; advance online publication, January 23, 2015; 10.1038/cgt.2014.78 Abstract | Full Text Performance-enhancing drugs: design and production of redirected chimeric antigen receptor (CAR) T cells B L Levine Cancer Gene Ther 2015 22: 79-84; advance online publication, February 13, 2015; 10.1038/cgt.2015.5 Abstract | Full Text Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapies X Wang and I Rivière Cancer Gene Ther 2015 22: 85-94; advance online publication, February 27, 2015; 10.1038/cgt.2014.81 Abstract | Full Text Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptor H Singh, J S E Moyes, M H Huls and L J N Cooper Cancer Gene Ther 2015 22: 95-100; advance online publication, January 16, 2015; 10.1038/cgt.2014.69 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.